NIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma

NCT02434081 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

NETWORK

Sponsor class

Conditions

Non-small Cell Lung Cancer Stage III

Interventions

DRUG: Nivolumab

Sponsor

ETOP IBCSG Partners Foundation

Collaborators

[object Object]
[object Object]